{"entity":{"type":"insider","cik":"0001767509","url":"/insider/0001767509","json_url":"/insider/0001767509.json","name":"CRG Partners III (Cayman) Lev AIV I L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":37,"n_filings":9,"first":"2020-12-22","last":"2023-09-29","span_basis":"filed_date"},"name_variants":[{"name":"CRG Partners III (Cayman) Lev AIV I L.P.","source":"filing","n_filings":9,"first_seen":"2020-12-22","last_seen":"2023-09-29"}],"transactions":[{"id":7836612,"accession":"0001209191-23-050864","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-23-050864","line_url":"/filing/0001209191-23-050864#line-8","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CR Group L.P.; CRG Partners III L.P.; CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2858980.0,"shares_display":"2,858,980","price_per_share":0.1575,"price_display":"0.16","price_state":"stated","total_value":450289.35,"total_display":"450,289.35","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-28","filed_date":"2023-09-29","scope":"insider"},{"id":7836610,"accession":"0001209191-23-050864","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-23-050864","line_url":"/filing/0001209191-23-050864#line-7","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CR Group L.P.; CRG Partners III L.P.; CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1937852.0,"shares_display":"1,937,852","price_per_share":0.1575,"price_display":"0.16","price_state":"stated","total_value":305211.69,"total_display":"305,211.69","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-28","filed_date":"2023-09-29","scope":"insider"},{"id":7836608,"accession":"0001209191-23-050864","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-050864","line_url":"/filing/0001209191-23-050864#line-6","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CR Group L.P.; CRG Partners III L.P.; CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1780317.0,"shares_display":"1,780,317","price_per_share":0.1575,"price_display":"0.16","price_state":"stated","total_value":280399.9275,"total_display":"280,399.93","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-28","filed_date":"2023-09-29","scope":"insider"},{"id":7836605,"accession":"0001209191-23-050864","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-050864","line_url":"/filing/0001209191-23-050864#line-5","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CR Group L.P.; CRG Partners III L.P.; CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":571796.0,"shares_display":"571,796","price_per_share":0.1575,"price_display":"0.16","price_state":"stated","total_value":90057.87,"total_display":"90,057.87","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-28","filed_date":"2023-09-29","scope":"insider"},{"id":7836604,"accession":"0001209191-23-050864","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-050864","line_url":"/filing/0001209191-23-050864#line-4","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CR Group L.P.; CRG Partners III L.P.; CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2391981.0,"shares_display":"2,391,981","price_per_share":0.1916,"price_display":"0.19","price_state":"stated","total_value":458303.5596,"total_display":"458,303.56","shares_owned_after":2858980.0,"shares_owned_after_display":"2,858,980","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-27","filed_date":"2023-09-29","scope":"insider"},{"id":7836602,"accession":"0001209191-23-050864","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-050864","line_url":"/filing/0001209191-23-050864#line-3","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CR Group L.P.; CRG Partners III L.P.; CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1621313.0,"shares_display":"1,621,313","price_per_share":0.1916,"price_display":"0.19","price_state":"stated","total_value":310643.5708,"total_display":"310,643.57","shares_owned_after":1937852.0,"shares_owned_after_display":"1,937,852","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-27","filed_date":"2023-09-29","scope":"insider"},{"id":7836601,"accession":"0001209191-23-050864","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-050864","line_url":"/filing/0001209191-23-050864#line-2","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CR Group L.P.; CRG Partners III L.P.; CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1489512.0,"shares_display":"1,489,512","price_per_share":0.1916,"price_display":"0.19","price_state":"stated","total_value":285390.4992,"total_display":"285,390.50","shares_owned_after":1780317.0,"shares_owned_after_display":"1,780,317","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-27","filed_date":"2023-09-29","scope":"insider"},{"id":7836599,"accession":"0001209191-23-050864","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-050864","line_url":"/filing/0001209191-23-050864#line-1","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CR Group L.P.; CRG Partners III L.P.; CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":478396.0,"shares_display":"478,396","price_per_share":0.1916,"price_display":"0.19","price_state":"stated","total_value":91660.6736,"total_display":"91,660.67","shares_owned_after":571796.0,"shares_owned_after_display":"571,796","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-27","filed_date":"2023-09-29","scope":"insider"},{"id":8726924,"accession":"0001209191-23-050732","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-050732","line_url":"/filing/0001209191-23-050732#line-4","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CR Group L.P.; CRG Partners III L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2156717.0,"shares_display":"2,156,717","price_per_share":0.2007,"price_display":"0.20","price_state":"stated","total_value":432853.1019,"total_display":"432,853.10","shares_owned_after":5250961.0,"shares_owned_after_display":"5,250,961","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-26","filed_date":"2023-09-28","scope":"insider"},{"id":8726921,"accession":"0001209191-23-050732","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-050732","line_url":"/filing/0001209191-23-050732#line-3","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CR Group L.P.; CRG Partners III L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1461849.0,"shares_display":"1,461,849","price_per_share":0.2007,"price_display":"0.20","price_state":"stated","total_value":293393.0943,"total_display":"293,393.09","shares_owned_after":3559165.0,"shares_owned_after_display":"3,559,165","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-26","filed_date":"2023-09-28","scope":"insider"},{"id":8726919,"accession":"0001209191-23-050732","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-050732","line_url":"/filing/0001209191-23-050732#line-2","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CR Group L.P.; CRG Partners III L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1343011.0,"shares_display":"1,343,011","price_per_share":0.2007,"price_display":"0.20","price_state":"stated","total_value":269542.3077,"total_display":"269,542.31","shares_owned_after":3269829.0,"shares_owned_after_display":"3,269,829","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-26","filed_date":"2023-09-28","scope":"insider"},{"id":8726917,"accession":"0001209191-23-050732","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-050732","line_url":"/filing/0001209191-23-050732#line-1","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CR Group L.P.; CRG Partners III L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":431343.0,"shares_display":"431,343","price_per_share":0.2007,"price_display":"0.20","price_state":"stated","total_value":86570.5401,"total_display":"86,570.54","shares_owned_after":1050192.0,"shares_owned_after_display":"1,050,192","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-26","filed_date":"2023-09-28","scope":"insider"},{"id":7899582,"accession":"0001209191-23-050677","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-050677","line_url":"/filing/0001209191-23-050677#line-4","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III L.P.; CR Group L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":99979.0,"shares_display":"99,979","price_per_share":0.25,"price_display":"0.25","price_state":"stated","total_value":24994.75,"total_display":"24,994.75","shares_owned_after":7407678.0,"shares_owned_after_display":"7,407,678","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-25","filed_date":"2023-09-27","scope":"insider"},{"id":7899579,"accession":"0001209191-23-050677","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-050677","line_url":"/filing/0001209191-23-050677#line-3","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III L.P.; CR Group L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67767.0,"shares_display":"67,767","price_per_share":0.25,"price_display":"0.25","price_state":"stated","total_value":16941.75,"total_display":"16,941.75","shares_owned_after":5021014.0,"shares_owned_after_display":"5,021,014","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-25","filed_date":"2023-09-27","scope":"insider"},{"id":7899576,"accession":"0001209191-23-050677","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-050677","line_url":"/filing/0001209191-23-050677#line-2","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III L.P.; CR Group L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62258.0,"shares_display":"62,258","price_per_share":0.25,"price_display":"0.25","price_state":"stated","total_value":15564.5,"total_display":"15,564.50","shares_owned_after":4612840.0,"shares_owned_after_display":"4,612,840","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-25","filed_date":"2023-09-27","scope":"insider"},{"id":7899571,"accession":"0001209191-23-050677","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-050677","line_url":"/filing/0001209191-23-050677#line-1","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III L.P.; CR Group L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19996.0,"shares_display":"19,996","price_per_share":0.25,"price_display":"0.25","price_state":"stated","total_value":4999.0,"total_display":"4,999.00","shares_owned_after":1481535.0,"shares_owned_after_display":"1,481,535","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-25","filed_date":"2023-09-27","scope":"insider"},{"id":8334957,"accession":"0001209191-23-050592","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-050592","line_url":"/filing/0001209191-23-050592#line-4","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CRG Partners III (Cayman) Lev AIV I L.P.; CR Group L.P.; CRG Partners III L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2031313.0,"shares_display":"2,031,313","price_per_share":0.2588,"price_display":"0.26","price_state":"stated","total_value":525703.8044,"total_display":"525,703.80","shares_owned_after":7507657.0,"shares_owned_after_display":"7,507,657","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-22","filed_date":"2023-09-26","scope":"insider"},{"id":8334954,"accession":"0001209191-23-050592","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-050592","line_url":"/filing/0001209191-23-050592#line-3","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CRG Partners III (Cayman) Lev AIV I L.P.; CR Group L.P.; CRG Partners III L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1376848.0,"shares_display":"1,376,848","price_per_share":0.2588,"price_display":"0.26","price_state":"stated","total_value":356328.2624,"total_display":"356,328.26","shares_owned_after":5088781.0,"shares_owned_after_display":"5,088,781","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-22","filed_date":"2023-09-26","scope":"insider"},{"id":8334950,"accession":"0001209191-23-050592","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-050592","line_url":"/filing/0001209191-23-050592#line-2","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CRG Partners III (Cayman) Lev AIV I L.P.; CR Group L.P.; CRG Partners III L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1264920.0,"shares_display":"1,264,920","price_per_share":0.2588,"price_display":"0.26","price_state":"stated","total_value":327361.296,"total_display":"327,361.30","shares_owned_after":4675098.0,"shares_owned_after_display":"4,675,098","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-22","filed_date":"2023-09-26","scope":"insider"},{"id":8334945,"accession":"0001209191-23-050592","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-050592","line_url":"/filing/0001209191-23-050592#line-1","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CRG Partners III (Cayman) Lev AIV I L.P.; CR Group L.P.; CRG Partners III L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":406263.0,"shares_display":"406,263","price_per_share":0.2588,"price_display":"0.26","price_state":"stated","total_value":105140.8644,"total_display":"105,140.86","shares_owned_after":1501531.0,"shares_owned_after_display":"1,501,531","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-22","filed_date":"2023-09-26","scope":"insider"},{"id":8609135,"accession":"0001209191-23-050530","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-050530","line_url":"/filing/0001209191-23-050530#line-4","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CRG Partners III L.P.; CR Group L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Lev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2534754.0,"shares_display":"2,534,754","price_per_share":0.3005,"price_display":"0.30","price_state":"stated","total_value":761693.577,"total_display":"761,693.58","shares_owned_after":9538970.0,"shares_owned_after_display":"9,538,970","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-21","filed_date":"2023-09-25","scope":"insider"},{"id":8609132,"accession":"0001209191-23-050530","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-050530","line_url":"/filing/0001209191-23-050530#line-3","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CRG Partners III L.P.; CR Group L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Lev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1718087.0,"shares_display":"1,718,087","price_per_share":0.3005,"price_display":"0.30","price_state":"stated","total_value":516285.1435,"total_display":"516,285.14","shares_owned_after":6465629.0,"shares_owned_after_display":"6,465,629","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-21","filed_date":"2023-09-25","scope":"insider"},{"id":8609128,"accession":"0001209191-23-050530","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-050530","line_url":"/filing/0001209191-23-050530#line-2","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CRG Partners III L.P.; CR Group L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Lev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1578419.0,"shares_display":"1,578,419","price_per_share":0.3005,"price_display":"0.30","price_state":"stated","total_value":474314.9095,"total_display":"474,314.91","shares_owned_after":5940018.0,"shares_owned_after_display":"5,940,018","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-21","filed_date":"2023-09-25","scope":"insider"},{"id":8609123,"accession":"0001209191-23-050530","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-050530","line_url":"/filing/0001209191-23-050530#line-1","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CRG Partners III L.P.; CR Group L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Lev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":506951.0,"shares_display":"506,951","price_per_share":0.3005,"price_display":"0.30","price_state":"stated","total_value":152338.7755,"total_display":"152,338.78","shares_owned_after":1907794.0,"shares_owned_after_display":"1,907,794","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-21","filed_date":"2023-09-25","scope":"insider"},{"id":7954887,"accession":"0001209191-23-050375","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-050375","line_url":"/filing/0001209191-23-050375#line-4","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CRG Partners III (Cayman) Unlev AIV I L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III L.P.; CR Group L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100836.0,"shares_display":"3,100,836","price_per_share":0.3106,"price_display":"0.31","price_state":"stated","total_value":963119.6616,"total_display":"963,119.66","shares_owned_after":12073724.0,"shares_owned_after_display":"12,073,724","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-20","filed_date":"2023-09-22","scope":"insider"},{"id":7954884,"accession":"0001209191-23-050375","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-050375","line_url":"/filing/0001209191-23-050375#line-3","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CRG Partners III (Cayman) Unlev AIV I L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III L.P.; CR Group L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2101784.0,"shares_display":"2,101,784","price_per_share":0.3106,"price_display":"0.31","price_state":"stated","total_value":652814.1104,"total_display":"652,814.11","shares_owned_after":8183716.0,"shares_owned_after_display":"8,183,716","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-20","filed_date":"2023-09-22","scope":"insider"},{"id":7954881,"accession":"0001209191-23-050375","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-050375","line_url":"/filing/0001209191-23-050375#line-2","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CRG Partners III (Cayman) Unlev AIV I L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III L.P.; CR Group L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1930923.0,"shares_display":"1,930,923","price_per_share":0.3106,"price_display":"0.31","price_state":"stated","total_value":599744.6838,"total_display":"599,744.68","shares_owned_after":7518437.0,"shares_owned_after_display":"7,518,437","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-20","filed_date":"2023-09-22","scope":"insider"},{"id":7954877,"accession":"0001209191-23-050375","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-050375","line_url":"/filing/0001209191-23-050375#line-1","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CRG Partners III (Cayman) Unlev AIV I L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III L.P.; CR Group L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":620167.0,"shares_display":"620,167","price_per_share":0.3106,"price_display":"0.31","price_state":"stated","total_value":192623.8702,"total_display":"192,623.87","shares_owned_after":2414745.0,"shares_owned_after_display":"2,414,745","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-20","filed_date":"2023-09-22","scope":"insider"},{"id":7973543,"accession":"0001209191-23-050273","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-050273","line_url":"/filing/0001209191-23-050273#line-4","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.; CRG Partners III L.P.; CR Group L.P.; CRG Partners III (Cayman) Lev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4159717.0,"shares_display":"4,159,717","price_per_share":0.366,"price_display":"0.37","price_state":"stated","total_value":1522456.422,"total_display":"1,522,456.42","shares_owned_after":15174560.0,"shares_owned_after_display":"15,174,560","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-19","filed_date":"2023-09-21","scope":"insider"},{"id":7973540,"accession":"0001209191-23-050273","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-050273","line_url":"/filing/0001209191-23-050273#line-3","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.; CRG Partners III L.P.; CR Group L.P.; CRG Partners III (Cayman) Lev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2819506.0,"shares_display":"2,819,506","price_per_share":0.366,"price_display":"0.37","price_state":"stated","total_value":1031939.196,"total_display":"1,031,939.20","shares_owned_after":10285500.0,"shares_owned_after_display":"10,285,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-19","filed_date":"2023-09-21","scope":"insider"},{"id":7973537,"accession":"0001209191-23-050273","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-050273","line_url":"/filing/0001209191-23-050273#line-2","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.; CRG Partners III L.P.; CR Group L.P.; CRG Partners III (Cayman) Lev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2590300.0,"shares_display":"2,590,300","price_per_share":0.366,"price_display":"0.37","price_state":"stated","total_value":948049.8,"total_display":"948,049.80","shares_owned_after":9449360.0,"shares_owned_after_display":"9,449,360","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-19","filed_date":"2023-09-21","scope":"insider"},{"id":7973533,"accession":"0001209191-23-050273","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-050273","line_url":"/filing/0001209191-23-050273#line-1","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":null,"owner_name":"CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.; CRG Partners III L.P.; CR Group L.P.; CRG Partners III (Cayman) Lev AIV I L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":831943.0,"shares_display":"831,943","price_per_share":0.366,"price_display":"0.37","price_state":"stated","total_value":304491.138,"total_display":"304,491.14","shares_owned_after":3034912.0,"shares_owned_after_display":"3,034,912","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-19","filed_date":"2023-09-21","scope":"insider"},{"id":2561198,"accession":"0001209191-20-065421","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-065421","line_url":"/filing/0001209191-20-065421#line-2","is_derivative":false,"issuer_cik":"0001637591","issuer_name":"Assertio Holdings, Inc.","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001637591","owner_cik":null,"owner_name":"CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.; Loan Security Holdings I LLC; CR Group L.P.; CRG Partners III L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III - Parallel Fund B (Cayman) L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1982851.0,"shares_display":"1,982,851","price_per_share":0.3682,"price_display":"0.37","price_state":"stated","total_value":730085.7382,"total_display":"730,085.74","shares_owned_after":200000.0,"shares_owned_after_display":"200,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-24","filed_date":"2020-12-29","scope":"insider"},{"id":2561195,"accession":"0001209191-20-065421","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-065421","line_url":"/filing/0001209191-20-065421#line-1","is_derivative":false,"issuer_cik":"0001637591","issuer_name":"Assertio Holdings, Inc.","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001637591","owner_cik":null,"owner_name":"CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.; Loan Security Holdings I LLC; CR Group L.P.; CRG Partners III L.P.; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III - Parallel Fund B (Cayman) L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6784334.0,"shares_display":"6,784,334","price_per_share":0.3745,"price_display":"0.37","price_state":"stated","total_value":2540733.083,"total_display":"2,540,733.08","shares_owned_after":2182851.0,"shares_owned_after_display":"2,182,851","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-23","filed_date":"2020-12-29","scope":"insider"},{"id":2446528,"accession":"0001209191-20-064951","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-064951","line_url":"/filing/0001209191-20-064951#line-3","is_derivative":false,"issuer_cik":"0001637591","issuer_name":"Assertio Holdings, Inc.","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001637591","owner_cik":null,"owner_name":"CRG Partners III L.P.; CR Group L.P.; Loan Security Holdings I LLC; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.; CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III - Parallel Fund B (Cayman) L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500000.0,"shares_display":"1,500,000","price_per_share":0.339,"price_display":"0.34","price_state":"stated","total_value":508500.0,"total_display":"508,500.00","shares_owned_after":8967185.0,"shares_owned_after_display":"8,967,185","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-22","filed_date":"2020-12-22","scope":"insider"},{"id":2446524,"accession":"0001209191-20-064951","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-064951","line_url":"/filing/0001209191-20-064951#line-2","is_derivative":false,"issuer_cik":"0001637591","issuer_name":"Assertio Holdings, Inc.","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001637591","owner_cik":null,"owner_name":"CRG Partners III L.P.; CR Group L.P.; Loan Security Holdings I LLC; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.; CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III - Parallel Fund B (Cayman) L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500000.0,"shares_display":"500,000","price_per_share":0.3602,"price_display":"0.36","price_state":"stated","total_value":180100.0,"total_display":"180,100.00","shares_owned_after":10467185.0,"shares_owned_after_display":"10,467,185","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-21","filed_date":"2020-12-22","scope":"insider"},{"id":2446520,"accession":"0001209191-20-064951","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-064951","line_url":"/filing/0001209191-20-064951#line-1","is_derivative":false,"issuer_cik":"0001637591","issuer_name":"Assertio Holdings, Inc.","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001637591","owner_cik":null,"owner_name":"CRG Partners III L.P.; CR Group L.P.; Loan Security Holdings I LLC; CRG Partners III - Parallel Fund (A) L.P.; CRG Partners III (Cayman) Unlev AIV I L.P.; CRG Partners III (Cayman) Lev AIV I L.P.; CRG Partners III - Parallel Fund B (Cayman) L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500000.0,"shares_display":"500,000","price_per_share":0.3776,"price_display":"0.38","price_state":"stated","total_value":188800.0,"total_display":"188,800.00","shares_owned_after":10967185.0,"shares_owned_after_display":"10,967,185","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001492674","name":"T2 Biosystems, Inc.","url":"/issuer/0001492674","role":"Ten percent owner","n_filings":7,"first_seen":"2023-09-21","last_seen":"2023-09-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001808665","name":"Assertio Holdings, Inc.","url":"/issuer/0001808665","role":"Ten percent owner","n_filings":2,"first_seen":"2020-12-22","last_seen":"2020-12-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001767509","retrieved_at":"2026-08-21T12:05:06+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}